Teratogenicity of SSRIs--serious concern or much ado about little?

Editorial

Michael F Greene. N Engl J Med. 2007.

. 2007 Jun 28;356(26):2732-3.

doi: 10.1056/NEJMe078079.

No abstract available

Comment on

First-trimester use of selective serotonin-reuptake inhibitors and the risk of birth defects.
Louik C, Lin AE, Werler MM, Hernández-Díaz S, Mitchell AA. Louik C, et al. N Engl J Med. 2007 Jun 28;356(26):2675-83. doi: 10.1056/NEJMoa067407. N Engl J Med. 2007. PMID: 17596601
Use of selective serotonin-reuptake inhibitors in pregnancy and the risk of birth defects.
Alwan S, Reefhuis J, Rasmussen SA, Olney RS, Friedman JM; National Birth Defects Prevention Study. Alwan S, et al. N Engl J Med. 2007 Jun 28;356(26):2684-92. doi: 10.1056/NEJMoa066584. N Engl J Med. 2007. PMID: 17596602